BIOMAT Database Logo BIOMAT Database Logo

[Effectiveness of trimecaine, a new anti-arrhythmia agent]. 1980

E I Gendenshteĭn, and I E Ganelina, and Ia V Kostin, and L M Kukuĭ, and A P Tsybusov

UI MeSH Term Description Entries
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000083 Acetanilides Compounds based on N-phenylacetamide, that are similar in structure to 2-PHENYLACETAMIDES. They are precursors of many other compounds. They were formerly used as ANALGESICS and ANTIPYRETICS, but often caused lethal METHEMOGLOBINEMIA. Acetylanilines,N-Phenylacetamides
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D001145 Arrhythmias, Cardiac Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction. Arrhythmia,Arrythmia,Cardiac Arrhythmia,Cardiac Arrhythmias,Cardiac Dysrhythmia,Arrhythmia, Cardiac,Dysrhythmia, Cardiac

Related Publications

E I Gendenshteĭn, and I E Ganelina, and Ia V Kostin, and L M Kukuĭ, and A P Tsybusov
[Comparative clinical study of the effectiveness of the new anti-arrhythmia agents, trimecaine and pyrromecaine].
January 1983, Biulleten' Vsesoiuznogo kardiologicheskogo nauchnogo tsentra AMN SSSR,
E I Gendenshteĭn, and I E Ganelina, and Ia V Kostin, and L M Kukuĭ, and A P Tsybusov
[Mexitil, a new anti-arrhythmia agent].
March 1980, Medizinische Klinik,
E I Gendenshteĭn, and I E Ganelina, and Ia V Kostin, and L M Kukuĭ, and A P Tsybusov
[Flecainide (Tambocor)--a new anti-arrhythmia agent].
January 1989, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
E I Gendenshteĭn, and I E Ganelina, and Ia V Kostin, and L M Kukuĭ, and A P Tsybusov
[Propafenone--a new generation anti-arrhythmia agent].
January 1980, Medizinische Klinik,
E I Gendenshteĭn, and I E Ganelina, and Ia V Kostin, and L M Kukuĭ, and A P Tsybusov
[Clinical evaluation of the anti-arrhythmia effect of trimecaine].
May 1983, Vrachebnoe delo,
E I Gendenshteĭn, and I E Ganelina, and Ia V Kostin, and L M Kukuĭ, and A P Tsybusov
[Brevikarin dihydrochloride--a new original anti-arrhythmia agent].
January 1988, Farmakologiia i toksikologiia,
E I Gendenshteĭn, and I E Ganelina, and Ia V Kostin, and L M Kukuĭ, and A P Tsybusov
[Pharmacological profile of a new anti-arrhythmia agent: bunaftide].
January 1972, Bollettino della Societa italiana di cardiologia,
E I Gendenshteĭn, and I E Ganelina, and Ia V Kostin, and L M Kukuĭ, and A P Tsybusov
[Clinical study of a new anti-arrhythmia agent: nadoxolol].
April 1976, Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille,
E I Gendenshteĭn, and I E Ganelina, and Ia V Kostin, and L M Kukuĭ, and A P Tsybusov
[Hemodynamic effects of a new anti-arrhythmia agent: mexiletine].
January 1980, Bollettino della Societa italiana di cardiologia,
E I Gendenshteĭn, and I E Ganelina, and Ia V Kostin, and L M Kukuĭ, and A P Tsybusov
[Lorcainid--electrophysiologic examinations of a new anti-arrhythmia agent].
January 1978, Acta medica Austriaca,
Copied contents to your clipboard!